Allergic Rhinitis Clinical Trial Landscape
Data updated: May 20, 2026
369 clinical trials tracked since 2008
Allergic Rhinitis is being studied across 369 clinical trials registered since 2008, with 35 programs currently active. The competitive pipeline includes 13 active Phase 3 trials, 17 active Phase 2 trials, and 4 active Phase 1 trials. Top industry sponsors include Genrix (Shanghai) Biopharmaceutical Co., Ltd., Prime Gene Therapeutics Co., Ltd., ALK-Abelló A/S.
35 active
/
369 total (since 2008)
4
Phase 1 Active
65 total
17
Phase 2 Active
127 total
13
Phase 3 Active
137 total
6
Phase 4 Active
66 total
Top Industry Sponsors
Sorted by active Active Done Failed
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 3 0 0
Prime Gene Therapeutics Co., Ltd. 2 0 0
ALK-Abelló A/S 1 9 1
EMS 1 1 3
Keymed Biosciences Co.Ltd 1 2 0
+ 10 more sponsors — see full table below
Featured Phase 3 Trials
NCT06339008 RECRUITING
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Eli Lilly and Company n=450
NCT07060885 RECRUITING
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
ALK-Abelló A/S n=300
NCT07291284 ACTIVE NOT RECRUITING
Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis
Longbio Pharma n=546
NCT07168473 RECRUITING
Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Daewon Pharmaceutical Co., Ltd. n=274
NCT07154342 RECRUITING
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Genrix (Shanghai) Biopharmaceutical Co., Ltd. n=150
+ 132 more Phase 3 trials — see full database below
Allergic Rhinitis — Trials Started by Year (last 10 years)
2016 9
2017 10
2018 16
2019 10
2020 10
2021 11
2022 13
2023 12
2024 10
2025 21
2026 10
TheraRadar.com
Full Trial Database
Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.
Top Sponsors (all-time)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 3
Prime Gene Therapeutics Co., Ltd. 2
ALK-Abelló A/S 11
EMS 5
Keymed Biosciences Co.Ltd 3
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 2
Longbio Pharma 2
Inmunotek S.L. 2
Eli Lilly 1
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. 1
Active Trials by Phase
Phase 1 4
Phase 2 17
Phase 3 13
Phase 4 6
Enrollment Size Distribution
1-50 102
51-200 129
201-500 75
501-1k 42
1k+ 10
All Industry Sponsors
Sorted by active Active Done Failed
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 3 0 0
Prime Gene Therapeutics Co., Ltd. 2 0 0
ALK-Abelló A/S 1 9 1
EMS 1 1 3
Keymed Biosciences Co.Ltd 1 2 0
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 1 1 0
Longbio Pharma 1 1 0
Inmunotek S.L. 1 0 1
Eli Lilly 1 0 0
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. 1 0 0
Jemincare 1 0 0
Akeso 1 0 0
AJU Pharm Co., Ltd. 1 0 0
Alixer Nexgen Therapeutics Limited 1 0 0
Daewon Pharmaceutical Co., Ltd. 1 0 0
NCT06339008 RECRUITING
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Eli Lilly and Company n=450
NCT07060885 RECRUITING
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
ALK-Abelló A/S n=300
NCT07291284 ACTIVE NOT RECRUITING
Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis
Longbio Pharma n=546
NCT07199257 NOT YET RECRUITING
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
Genrix (Shanghai) Biopharmaceutical Co., Ltd. n=144
NCT07168473 RECRUITING
Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Daewon Pharmaceutical Co., Ltd. n=274
NCT07154342 RECRUITING
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Genrix (Shanghai) Biopharmaceutical Co., Ltd. n=150
NCT07146126 NOT YET RECRUITING
A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
Prime Gene Therapeutics Co., Ltd. n=600
NCT06846385 RECRUITING
Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd n=160
NCT06916884 RECRUITING
Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine
Laboratorios Silanes S.A. de C.V. n=70
NCT06061848 RECRUITING
Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
Lars Olaf Cardell n=360
NCT06608017 NOT YET RECRUITING
Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)
Chinese University of Hong Kong n=140
NCT06272409 NOT YET RECRUITING
Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.
EMS n=318
NCT05641272 NOT YET RECRUITING
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Inmunotek S.L. n=90
NCT03369704 COMPLETED
Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
Novartis Pharmaceuticals n=337
NCT01861522 COMPLETED
The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Tanabe Pharma Corporation n=473
NCT01900054 COMPLETED
A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Tanabe Pharma Corporation n=58
NCT01425632 COMPLETED
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Tanabe Pharma Corporation n=490
NCT05637710 WITHDRAWN
Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil
Eurofarma Laboratorios S.A.
NCT05299086 COMPLETED
As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis
Mahidol University n=68
NCT05692154 COMPLETED
A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
Opella Healthcare Group SAS, a Sanofi Company n=95
NCT05191186 COMPLETED
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
Aarhus University Hospital n=450
NCT05214911 COMPLETED
Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children
Eurofarma Laboratorios S.A. n=262
NCT05540717 COMPLETED
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
Allergy Therapeutics n=555
NCT01199133 TERMINATED
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children
Stallergenes Greer n=471
NCT05908032 COMPLETED
Study of CM310 in Subjects With Allergic Rhinitis
Keymed Biosciences Co.Ltd n=108
NCT01673620 COMPLETED
A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)
Organon and Co n=69
NCT01852812 COMPLETED
Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)
Organon and Co n=87
NCT01918033 COMPLETED
A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
Organon and Co n=608
NCT01857063 COMPLETED
Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)
Organon and Co n=220
NCT04981717 TERMINATED
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
Regeneron Pharmaceuticals n=446
NCT00732381 COMPLETED
Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)
Organon and Co n=351
NCT00599027 COMPLETED
An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma
Organon and Co n=51
NCT00733005 COMPLETED
Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)
Organon and Co n=324
NCT02320396 COMPLETED
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Organon and Co n=449
NCT04874714 TERMINATED
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Inmunotek S.L. n=18
NCT04790487 WITHDRAWN
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
Larkin Community Hospital
NCT04729517 COMPLETED
Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients
Abdi Ibrahim Ilac San. ve Tic A.S. n=210
NCT05590598 COMPLETED
Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.
Sandoz n=472
NCT05311475 COMPLETED
Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis
Sandoz n=669
NCT02246920 TERMINATED
Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients
Teva Pharmaceuticals USA n=1,474
NCT01055756 WITHDRAWN
Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis
Azidus Brasil
NCT04709575 COMPLETED
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
Regeneron Pharmaceuticals n=353
NCT04670653 WITHDRAWN
Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis
EMS
NCT04637425 COMPLETED
Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus
Medical University of Lublin n=70
NCT04802616 COMPLETED
The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells
Medical University of Lublin n=80
NCT05276336 COMPLETED
The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis
Indonesia University n=32
NCT04264637 COMPLETED
Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis
Bayer n=110
NCT00728416 COMPLETED
Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)
Organon and Co n=333
NCT04182919 COMPLETED
"Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients"
Chulalongkorn University n=267
NCT01024608 COMPLETED
Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)
Teva Branded Pharmaceutical Products R&D, Inc. n=340
NCT02230696 COMPLETED
Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis
Padagis LLC n=951
NCT01673659 COMPLETED
A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)
Padagis LLC n=1,220
NCT04270552 COMPLETED
Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis
Medical University of Lublin n=76
NCT02953379 WITHDRAWN
Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
EMS
NCT02953366 WITHDRAWN
Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
EMS
NCT03755557 COMPLETED
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
Marinomed Biotech AG n=82
NCT04534452 COMPLETED
Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study
Bayer n=347
NCT03990272 COMPLETED
Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
Beijing Tongren Hospital n=702
NCT04332978 COMPLETED
Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene
Libbs Farmacêutica LTDA n=566
NCT04324918 COMPLETED
Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
Hanmi Pharmaceutical Company Limited n=174
NCT02709538 COMPLETED
Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)
Glenmark Specialty S.A. n=601
NCT04210193 COMPLETED
Is Intralymphatic Allergen Immunotherapy Effective and Safe?
Lars Olaf Cardell n=15
NCT03463031 COMPLETED
Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. n=446
NCT03649139 COMPLETED
Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
Beijing Tongren Hospital n=71
NCT01694836 COMPLETED
Depigoid Birch 5000 Longterm Study in Adults and Adolescents
Leti Pharma GmbH n=634
NCT02560948 COMPLETED
Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
BioTech Tools S.A. n=554
NCT01484119 COMPLETED
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Idorsia Pharmaceuticals Ltd. n=630
NCT02631551 COMPLETED
Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. n=1,180
NCT03655210 COMPLETED
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
Hanlim Pharm. Co., Ltd. n=272
NCT02423707 COMPLETED
Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy
Karolinska Institutet n=110
NCT02870205 COMPLETED
Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. n=1,176
NCT01982916 COMPLETED
Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
Ahn-Gook Pharmaceuticals Co.,Ltd n=324
NCT01372865 COMPLETED
A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)
Eurofarma Laboratorios S.A. n=364
NCT01231464 COMPLETED
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis
GlaxoSmithKline n=365
NCT03157505 COMPLETED
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
Medical University of Silesia n=78
NCT02155881 COMPLETED
Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
AstraZeneca n=80
NCT03039816 COMPLETED
Cellulose Powder Against Grass Pollen Allergic Rhinitis
Nasaleze International Ltd n=108
NCT00955825 COMPLETED
Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis
Stallergenes Greer n=473
NCT01603056 COMPLETED
Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis
ALK-Abelló A/S n=617
NCT01228630 COMPLETED
Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.
Azidus Brasil n=156
NCT00790023 COMPLETED
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
Sumitomo Pharma America, Inc. n=707
NCT02245360 COMPLETED
Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis
Abbott n=107
NCT02125253 COMPLETED
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Amneal Pharmaceuticals, LLC n=811
NCT01783548 COMPLETED
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Teva Branded Pharmaceutical Products R&D, Inc. n=547
NCT01697956 COMPLETED
Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)
Teva Branded Pharmaceutical Products R&D, Inc. n=99
NCT02552667 COMPLETED
Efficacy and Safety of HCP1102 Capsule
Hanmi Pharmaceutical Company Limited n=228
NCT01116778 COMPLETED
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
GenMont Biotech Incorporation n=236
NCT01631032 COMPLETED
Effect of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis
Chang Gung Memorial Hospital n=112
NCT01022047 COMPLETED
Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis
Eurofarma Laboratorios S.A. n=280
NCT01915823 COMPLETED
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Meda Pharmaceuticals n=348
NCT01794741 COMPLETED
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Meda Pharmaceuticals n=405
NCT00976209 COMPLETED
Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
Bayer n=331
NCT01413958 COMPLETED
Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)
Bayer n=575
NCT00628108 COMPLETED
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
UCB Pharma n=69
NCT00619801 COMPLETED
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin
UCB Pharma n=173
NCT01307319 COMPLETED
Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
Teva Branded Pharmaceutical Products R&D, Inc. n=715
NCT01529229 COMPLETED
Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment
EMS n=210
NCT00599872 COMPLETED
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
Greer Laboratories n=430
NCT01568190 COMPLETED
An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy
ALK-Abelló A/S n=102
NCT02273817 COMPLETED
A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis
Apotex Inc. n=580
NCT01400828 COMPLETED
Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis
Yuhan Corporation n=239
NCT01378429 COMPLETED
Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis
Sumitomo Pharma America, Inc. n=89
NCT01458275 COMPLETED
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
Sumitomo Pharma America, Inc. n=847
NCT01451541 COMPLETED
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Sumitomo Pharma America, Inc. n=848
NCT02130440 COMPLETED
Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis
University of Campania Luigi Vanvitelli n=100
NCT01817790 COMPLETED
Assessment of Fluticasone Propionate on Ocular Allergy Symptoms
GlaxoSmithKline n=626
NCT00916422 COMPLETED
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
Laboratorios Leti, S.L. n=153
NCT01470053 COMPLETED
Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis
Hanlim Pharm. Co., Ltd. n=347
NCT00791102 COMPLETED
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
University of Chicago n=20
NCT00883168 COMPLETED
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Meda Pharmaceuticals n=1,791
NCT01674595 COMPLETED
An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy
ALK-Abelló A/S n=93
NCT01401465 COMPLETED
Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
Sumitomo Pharma America, Inc. n=327
NCT01640535 COMPLETED
Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
Hanmi Pharmaceutical Company Limited n=283
NCT01731249 COMPLETED
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis
Stallergenes Greer n=574
NCT01287364 COMPLETED
Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis
Sumitomo Pharma America, Inc. n=185
NCT00651118 COMPLETED
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Meda Pharmaceuticals n=832
NCT00740792 COMPLETED
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Meda Pharmaceuticals n=776
NCT01033825 COMPLETED
Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis
Sumitomo Pharma America, Inc. n=310
NCT01133626 COMPLETED
Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)
Teva Branded Pharmaceutical Products R&D, Inc. n=107
NCT01067105 COMPLETED
A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
Sumitomo Pharma America, Inc. n=824
NCT01010971 COMPLETED
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older
Sumitomo Pharma America, Inc. n=671
NCT00953147 COMPLETED
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
Sumitomo Pharma America, Inc. n=1,110
NCT01018862 COMPLETED
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Meda Pharmaceuticals n=489
NCT01539304 COMPLETED
Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis
SamA Pharmaceutical Co., Ltd n=245
NCT01293201 COMPLETED
Trial of STAHIST in Seasonal Allergic Rhinitis
Magna Pharmaceuticals, Inc. n=290
NCT01012531 COMPLETED
Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen
Roxall Medizin n=121
NCT01000792 COMPLETED
3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
Clinical Research International Limited n=1
NCT01113489 COMPLETED
Assessment of Oxidative Stress Markers in the Upper and Lower Airways of Atopic Children Treated With Nebulized Beclomethasone
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy n=32
NCT00824473 COMPLETED
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Meda Pharmaceuticals n=506
Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only